Harrow Health Inc's stock surged 5.06% during intraday trading on Wednesday, reflecting strong investor sentiment following a series of positive analyst actions.
The healthcare company received favorable attention from multiple analysts, with Lake Street maintaining a Buy rating and setting a price target of $60.00. Additionally, BTIG maintained its price target of $63.00 per share for Harrow Health, while Cantor Fitzgerald continued to rate the stock as Overweight.
These analyst endorsements suggest confidence in the company's prospects and may have contributed to the stock's significant upward movement during the trading session.
Comments